![DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer | BMC Cancer | Full Text DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-965/MediaObjects/12885_2014_Article_5144_Fig1_HTML.jpg)
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer | BMC Cancer | Full Text
![The role of ubiquitination in tumorigenesis and targeted drug discovery | Signal Transduction and Targeted Therapy The role of ubiquitination in tumorigenesis and targeted drug discovery | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-0107-0/MediaObjects/41392_2020_107_Fig1_HTML.png)
The role of ubiquitination in tumorigenesis and targeted drug discovery | Signal Transduction and Targeted Therapy
![Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion](https://www.spandidos-publications.com/article_images/ol/15/6/ol-15-06-8573-g01.jpg)
Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer | Aging
![Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis](https://www.spandidos-publications.com/article_images/or/38/2/OR-38-02-1035-g03.jpg)
Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer | Aging
![Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis](https://www.spandidos-publications.com/article_images/or/38/2/OR-38-02-1035-g00.jpg)
Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer | Aging
![Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk | Science Advances Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk | Science Advances](https://www.science.org/cms/10.1126/sciadv.abj7176/asset/d0fd42ae-ea85-4363-b84e-47497bbc8a53/assets/images/large/sciadv.abj7176-f1.jpg)